Citigroup Comments On Regeneron (REGN)

February 10, 2017 6:13 AM EST Send to a Friend
Citi maintains Buy Regeneron Pharma (NASDAQ: REGN) price target of $420.00.Analyst Dr. Robyn Karnauskas comments "New guidance for US Eylea ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login